IL90515A - History of 1,3,4,5-Tetrahydro-4-Phenyl H2-1-Benzazpin-2-One and 2,3-Dihydro-2-Phenyl-1,5-Benzoltazepine-H) -54 (- On, Processes For their preparation and pharmaceutical preparations - Google Patents

History of 1,3,4,5-Tetrahydro-4-Phenyl H2-1-Benzazpin-2-One and 2,3-Dihydro-2-Phenyl-1,5-Benzoltazepine-H) -54 (- On, Processes For their preparation and pharmaceutical preparations

Info

Publication number
IL90515A
IL90515A IL9051589A IL9051589A IL90515A IL 90515 A IL90515 A IL 90515A IL 9051589 A IL9051589 A IL 9051589A IL 9051589 A IL9051589 A IL 9051589A IL 90515 A IL90515 A IL 90515A
Authority
IL
Israel
Prior art keywords
compound
methoxyphenyl
hydroxy
benzazepin
tetrahydro
Prior art date
Application number
IL9051589A
Other languages
English (en)
Hebrew (he)
Other versions
IL90515A0 (en
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of IL90515A0 publication Critical patent/IL90515A0/xx
Publication of IL90515A publication Critical patent/IL90515A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Hydrogenated Pyridines (AREA)
IL9051589A 1988-06-20 1989-06-02 History of 1,3,4,5-Tetrahydro-4-Phenyl H2-1-Benzazpin-2-One and 2,3-Dihydro-2-Phenyl-1,5-Benzoltazepine-H) -54 (- On, Processes For their preparation and pharmaceutical preparations IL90515A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20852188A 1988-06-20 1988-06-20
US07/353,806 US4902684A (en) 1988-06-20 1989-05-22 Benzazepine and benzothiazepine derivatives

Publications (2)

Publication Number Publication Date
IL90515A0 IL90515A0 (en) 1990-01-18
IL90515A true IL90515A (en) 1994-07-31

Family

ID=26903265

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9051589A IL90515A (en) 1988-06-20 1989-06-02 History of 1,3,4,5-Tetrahydro-4-Phenyl H2-1-Benzazpin-2-One and 2,3-Dihydro-2-Phenyl-1,5-Benzoltazepine-H) -54 (- On, Processes For their preparation and pharmaceutical preparations

Country Status (29)

Country Link
US (1) US4902684A (fr)
JP (1) JP2793674B2 (fr)
KR (1) KR970002633B1 (fr)
CN (1) CN1027262C (fr)
AT (1) AT398567B (fr)
AU (1) AU614399B2 (fr)
BE (1) BE1003305A4 (fr)
CA (1) CA1336975C (fr)
CH (1) CH681723A5 (fr)
EG (1) EG19071A (fr)
ES (1) ES2016467A6 (fr)
FI (1) FI94246C (fr)
FR (1) FR2632953B1 (fr)
GB (1) GB2231329B (fr)
GR (1) GR1002099B (fr)
HU (1) HU210929B (fr)
IE (1) IE64242B1 (fr)
IL (1) IL90515A (fr)
IT (1) IT1230884B (fr)
LU (1) LU87865A1 (fr)
NL (1) NL8920642A (fr)
NO (1) NO179449C (fr)
NZ (1) NZ229612A (fr)
PL (1) PL162313B1 (fr)
PT (1) PT90914B (fr)
RU (1) RU2090562C1 (fr)
SE (1) SE9004060L (fr)
WO (1) WO1989012633A1 (fr)
YU (1) YU121389A (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008284A (en) * 1989-02-15 1991-04-16 E. R. Squibb & Sons, Inc. Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation
US4946840A (en) * 1989-04-06 1990-08-07 E. R. Squibb & Sons, Inc. Benzazepine and benzothiazepine derivatives
US4963671A (en) * 1989-11-20 1990-10-16 E. R. Squibb & Sons, Inc. Process for resolving chiral intermediates used in making calcium channel blockers
US5112969A (en) * 1990-04-02 1992-05-12 Merrell Dow Pharmaceuticals Inc. Cyano esters and azepinones
IT1240686B (it) * 1990-04-27 1993-12-17 Luso Farmaco Inst Derivati 1,5-benzotiazepinonici, loro preparazione e uso farmaceutico
IT1244878B (it) * 1990-12-11 1994-09-12 Lusochimica Spa Processo per la preparazione del (+)-cis-3-(acetossi)-5-!2-( dimetilammino)etil!-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin- 4-(5h)-one cloridrato
AU666318B2 (en) * 1991-06-28 1996-02-08 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
IT1255545B (it) * 1992-10-23 1995-11-09 Procedimento per la preparazione di diltiazem
CA2098446A1 (fr) * 1992-09-30 1994-03-31 Eckard Weber 2,5-dihydro-2,5-dioxo-1h-azepines et 2,5-dihydro-2-oxo-1h-azepines et leur utilisation comme antagonistes des recepteurs de l'acide amine excitateur et de la glycine
JPH09500134A (ja) * 1993-07-16 1997-01-07 メルク エンド カンパニー インコーポレーテッド ベンゾオキサジノンおよびベンゾピリミジノンピペリジニル早産防止オキシトシン受容体拮抗剤
US5854233A (en) * 1993-09-08 1998-12-29 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
US6174917B1 (en) 1993-09-08 2001-01-16 Pharmacy And Therapeutic Advisory Consultancy Ltd. Method of treating liver disease and like indications with vasodilating agents
US6013645A (en) * 1994-03-24 2000-01-11 Hoechst Marion Roussel, Inc. Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives
US5580867A (en) * 1994-09-09 1996-12-03 Universite De Montreal Myocardial protection during ischemia and reperfusion
EP0950057B1 (fr) * 1996-12-10 2002-11-13 Abbott Laboratories Enantiomeres 3-pyridyl et leur utilisation comme analgesiques
US6277844B1 (en) 1998-09-14 2001-08-21 Sydney Spector Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
US6472533B1 (en) 1999-04-08 2002-10-29 The Texas A & M University System Ligands for chiral catalysis
GB9907895D0 (en) * 1999-04-08 1999-06-02 Texas A & M Univ Sys Novel ligands for chiral catalysis
CA2482320C (fr) * 2002-04-19 2010-02-09 Georg T. Wondrak Procedes de modulation de la phototoxicite

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3312691A (en) * 1963-08-23 1967-04-04 Ciba Geigy Corp 2, 3, 4, 5-tetrahydro-1-benzazepin-2-ones
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
JPS59191036A (ja) * 1983-04-14 1984-10-30 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
GB8316032D0 (en) * 1983-06-11 1983-07-13 Tanabe Seiyaku Co Benzothiazepine derivatives
GB2154577A (en) * 1984-02-18 1985-09-11 Tanabe Seiyaku Co 1,5-benzothiazepines
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
GB2154578A (en) * 1984-02-18 1985-09-11 Tanabe Seiyaku Co Novel 1,5-benzothiazepine derivatives and processes for preparing the same
GB2167063A (en) * 1984-11-17 1986-05-21 Tanabe Seiyaku Co 6 or 9-chloro-1, 5-benzothiazepine derivatives
CA1271747A (fr) * 1985-06-12 1990-07-17 David M. Floyd Derives de benzazepines
US4748239A (en) * 1985-06-12 1988-05-31 E. R. Squibb & Sons, Inc. Benzazepine derivatives
US4584131A (en) * 1985-06-20 1986-04-22 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
DE3717561A1 (de) * 1987-05-25 1988-12-08 Thomae Gmbh Dr K Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA1271748A (fr) * 1985-12-12 1990-07-17 Jagabandhu Das Derives de benzazepine
FR2597097B1 (fr) * 1986-04-15 1988-12-02 Synthelabo Derives de benzothiazepine-1, 5, leur preparation et leur application en therapeutique
EP0256888B1 (fr) * 1986-08-20 1991-07-03 McNeilab, Inc. Benzothiazépines vasodilatatrices substituées par aralkyle
US4729994A (en) * 1986-08-20 1988-03-08 Mcneilab, Inc. Benzothiazepine vasodilators having aralkyl substitution
US4694002A (en) * 1986-08-21 1987-09-15 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
US4752645A (en) * 1986-10-09 1988-06-21 E. R. Squibb & Sons, Inc. Benzazepine derivatives
ZA893392B (en) * 1988-05-24 1990-01-31 Hoffmann La Roche Process for the manufacture of optically active naphthothiazepinones

Also Published As

Publication number Publication date
PL162313B1 (pl) 1993-09-30
ATA901089A (de) 1994-05-15
NO179449C (no) 1996-10-09
FR2632953A1 (fr) 1989-12-22
IE891957L (en) 1989-12-20
EG19071A (en) 1994-07-30
HUT59908A (en) 1992-07-28
HU894298D0 (en) 1991-01-28
GR1002099B (en) 1995-12-28
IE64242B1 (en) 1995-07-26
ES2016467A6 (es) 1990-11-01
AT398567B (de) 1994-12-27
AU3859389A (en) 1990-01-12
KR920700207A (ko) 1992-02-19
SE9004060L (sv) 1992-06-20
PT90914B (pt) 1994-12-30
RU2090562C1 (ru) 1997-09-20
IT8920933A0 (it) 1989-06-20
US4902684A (en) 1990-02-20
PT90914A (pt) 1989-12-29
CA1336975C (fr) 1995-09-12
GR890100410A (el) 1990-05-11
NO179449B (no) 1996-07-01
BE1003305A4 (fr) 1992-02-25
HU210929B (en) 1995-09-28
FR2632953B1 (fr) 1992-05-29
SE9004060D0 (sv) 1990-12-19
FI94246B (fi) 1995-04-28
IL90515A0 (en) 1990-01-18
FI900813A0 (fi) 1990-02-19
GB2231329B (en) 1992-10-21
LU87865A1 (de) 1991-12-16
NO905485D0 (no) 1990-12-19
WO1989012633A1 (fr) 1989-12-28
YU121389A (en) 1991-04-30
CN1039585A (zh) 1990-02-14
NL8920642A (nl) 1990-06-01
GB9002587D0 (en) 1990-08-29
KR970002633B1 (en) 1997-03-06
JP2793674B2 (ja) 1998-09-03
NZ229612A (en) 1992-07-28
GB2231329A (en) 1990-11-14
CN1027262C (zh) 1995-01-04
NO905485L (no) 1991-02-19
AU614399B2 (en) 1991-08-29
JPH04502002A (ja) 1992-04-09
CH681723A5 (fr) 1993-05-14
FI94246C (fi) 1995-08-10
IT1230884B (it) 1991-11-08

Similar Documents

Publication Publication Date Title
CA1336975C (fr) Benzazepine et derives benzothiazepine
EP1856096B1 (fr) Derives de phenylglycinamide utilises comme anticoagulants
KR0167349B1 (ko) 벤조헤테로 고리 화합물
CA2063185A1 (fr) Lactames a anneaux benzo condenses qui favorisent la liberation de somatotrophine
EP1093372A1 (fr) COMPOSES D'ACIDES AMINES CYCLIQUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT ET METHODES D'INHIBITION DE LA LIBERATION DU PEPTIDE $g(b)-AMYLOIDE ET/OU DE SA SYNTHESE A L'AIDE DE CES COMPOSES
HU214578B (hu) Eljárás aril-acetamidok, valamint hatóanyagként ezen vegyületeket tartalmazó gyógyászati készítmények előállítására
CA2877187A1 (fr) Benzo[b]azepin-2-ones inhibitrices de la proliferation
US5817654A (en) N-substituted naphthofused lactams
US4748239A (en) Benzazepine derivatives
JP4618127B2 (ja) １，３−ジヒドロ−２ｈ−インドール−２−オン誘導体
JP4350948B2 (ja) オキシトシン調節活性を有するピロリジンエステル誘導体
AU609169B2 (en) Benzazepines derivatives
CZ915486A3 (en) Benzazepine derivatives and process for preparing thereof
US4946840A (en) Benzazepine and benzothiazepine derivatives
RU2026296C1 (ru) Способ получения азотсодержащих гетероциклических соединений или их фармацевтическиприемлемых солей
EP0925300A1 (fr) Composes pharmaceutiquement actifs et leurs methodes d'utilisation
PH26646A (en) Benzazepine and benzothiazepine derivatives
JP2009517351A (ja) 化学物質
EA001658B1 (ru) Хиноксалиндионы
US20060124049A1 (en) Crystalline form
WO2003101490A1 (fr) Composition de medicament contenant un antagoniste des canaux calciques

Legal Events

Date Code Title Description
KB Patent renewed
RH1 Patent not in force